Effects of an altered developmental pattern on amino acid uptake for a protoplast isolate of the fungus Entomophaga aulicae under mass-fermentation conditions

1986 ◽  
Vol 32 (11) ◽  
pp. 855-860 ◽  
Author(s):  
Richard A. Nolan

The effects of an altered developmental pattern on amino acid uptake for a protoplast isolate of the fungus Entomophaga aulicae were studied under mass-fermentation conditions. Isolate 655A had previously developed through the hyphal body stage, but subsequently lost this ability (then designated I655B) and then developed only as far as the germination of the late fusion sphere stage. This alteration in developmental pattern was accompanied by a shift in the overall amino acid uptake pattern. For comparative purposes, another isolate (I521) which developed only as far as the germination of the late fusion sphere stage was included. The general amino acid uptake patterns fell into three categories and emphasize the similarity of I521 and I655B: (i) earlier and more complete final utilization by isolates 521 and 655B for glutamine, leucine, aspartic acid, threonine, and methionine, (ii) earlier utilization by isolate 655A with more complete final utilization by isolates 521 and 655B for asparagine and proline, and (iii) earlier utilization by isolates 521 and 655A with more complete final utilization by isolates 521 and 655B for serine and tyrosine. The first detectable utilization of serine coincided with late fusion sphere germination for isolates 521 and 655B. During the rapid increase in hyphal body levels for I655A, all added amino acids (except proline, asparagine, and serine which were first utilized earlier) were utilized for the first time. Except for the timing of the initial day of detectable utilization, the pattern of glucose utilization was similar for all three isolates.

1993 ◽  
Vol 39 (7) ◽  
pp. 701-708
Author(s):  
Richard A. Nolan

The effects of three different media on amino acid uptake and production and glucose and oxygen utilization during protoplast growth and hyphal body production by the fungus Entomophaga aulicae under fermentation conditions were studied. The three media consisted of a basal medium plus either (i) 2.8% fetal calf serum, (ii) 0.8% tryptic soy broth plus 0.4% bovine serum albumin, or (iii) 0.8% tryptic soy broth plus 0.4% calcium caseinate. The protoplasts grew most rapidly (initial peaks on days 2 and 3) and hyphal bodies were detected first (day 3) in the media containing albumin and caseinate. The day 9 hyphal body yields were 3.1 × 107, 7.5 × 108, and 3.1 × 109/10 L in media containing the serum, albumin, and caseinate, respectively. Growth in the albumin and caseinate media also gave the first detectable glucose utilization (days 2 and 3, respectively) and this rapidly increased to 94.9 and 90.6% utilization, respectively, on day 4. Oxygen and glucose utilization were closely related. During protoplast growth prior to hyphal body production, the only common pattern detected was the initial utilization of glutamine in serum- and caseinate-containing media. During the initial period of hyphal body production, cysteic acid, threonine, serine, asparagine, leucine, tyrosine, phenylalanine, and arginine were first utilized and glycine, alanine, and ammonia were first produced in the albumin and caseinate media. At this time (days 3–5), glutamine, proline, cystine, and tryptophan were first utilized and valine and histidine were produced in the albumin medium, and methionine was first utilized and cystathionine produced in the caseinate medium. Four main patterns of overall amino acid utilization and production were identified. The delay in major protoplast growth in the basal medium plus fetal calf serum is felt to result from inhibition by free fatty acids in the serum. Protein utilization was not detected and its main function is considered to be enhancement of protoplast stability against fermentation shear forces.Key words: Entomophaga aulicae, physiology, fermentation growth, protoplasts, hyphal bodies.


Diagnostics ◽  
2020 ◽  
Vol 10 (12) ◽  
pp. 1049
Author(s):  
Csaba Juhász ◽  
Sandeep Mittal

Epilepsy is a common clinical manifestation and a source of significant morbidity in patients with brain tumors. Neuroimaging has a pivotal role in neuro-oncology practice, including tumor detection, differentiation, grading, treatment guidance, and posttreatment monitoring. In this review, we highlight studies demonstrating that imaging can also provide information about brain tumor-associated epileptogenicity and assist delineation of the peritumoral epileptic cortex to optimize postsurgical seizure outcome. Most studies focused on gliomas and glioneuronal tumors where positron emission tomography (PET) and advanced magnetic resonance imaging (MRI) techniques can detect metabolic and biochemical changes associated with altered amino acid transport and metabolism, neuroinflammation, and neurotransmitter abnormalities in and around epileptogenic tumors. PET imaging of amino acid uptake and metabolism as well as activated microglia can detect interictal or peri-ictal cortical increased uptake (as compared to non-epileptic cortex) associated with tumor-associated epilepsy. Metabolic tumor volumes may predict seizure outcome based on objective treatment response during glioma chemotherapy. Advanced MRI, especially glutamate imaging, can detect neurotransmitter changes around epileptogenic brain tumors. Recently, developed PET radiotracers targeting specific glutamate receptor types may also identify therapeutic targets for pharmacologic seizure control. Further studies with advanced multimodal imaging approaches may facilitate development of precision treatment strategies to control brain tumor-associated epilepsy.


2007 ◽  
Vol 282 (18) ◽  
pp. e13-e15
Author(s):  
Nicole Kresge ◽  
Robert D. Simoni ◽  
Robert L. Hill

Cancers ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 125
Author(s):  
Uğur Kahya ◽  
Ayşe Sedef Köseer ◽  
Anna Dubrovska

Tumorigenesis is driven by metabolic reprogramming. Oncogenic mutations and epigenetic alterations that cause metabolic rewiring may also upregulate the reactive oxygen species (ROS). Precise regulation of the intracellular ROS levels is critical for tumor cell growth and survival. High ROS production leads to the damage of vital macromolecules, such as DNA, proteins, and lipids, causing genomic instability and further tumor evolution. One of the hallmarks of cancer metabolism is deregulated amino acid uptake. In fast-growing tumors, amino acids are not only the source of energy and building intermediates but also critical regulators of redox homeostasis. Amino acid uptake regulates the intracellular glutathione (GSH) levels, endoplasmic reticulum stress, unfolded protein response signaling, mTOR-mediated antioxidant defense, and epigenetic adaptations of tumor cells to oxidative stress. This review summarizes the role of amino acid transporters as the defender of tumor antioxidant system and genome integrity and discusses them as promising therapeutic targets and tumor imaging tools.


1962 ◽  
Vol 237 (3) ◽  
pp. 803-806
Author(s):  
Gordon Guroff ◽  
Sidney Udenfriend

1968 ◽  
Vol 243 (8) ◽  
pp. 1846-1853 ◽  
Author(s):  
L J Elsas ◽  
I Albrecht ◽  
L E Rosenberg

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Nana Kobayashi ◽  
Shogo Okazaki ◽  
Oltea Sampetrean ◽  
Junichiro Irie ◽  
Hiroshi Itoh ◽  
...  

1984 ◽  
Vol 259 (8) ◽  
pp. 5295-5300
Author(s):  
P Cardelli-Cangiano ◽  
C Cangiano ◽  
J H James ◽  
F Ceci ◽  
J E Fischer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document